BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2.04 Cr | ₹-6.41 Cr | ₹7.64 Cr | ₹-1.63 Cr | ₹-6.68 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2.04 Cr |
| Mar2024 | ₹-6.41 Cr |
| Mar2023 | ₹7.64 Cr |
| Mar2022 | ₹-1.63 Cr |
| Mar2021 | ₹-6.68 Cr |
How is Net Cash Inflow / Outflow of BAFNA PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.04 Cr | Positive | |
| Mar2024 | ₹-6.41 Cr | Negative | |
| Mar2023 | ₹7.64 Cr | Positive | |
| Mar2022 | ₹-1.63 Cr | Negative | |
| Mar2021 | ₹-6.68 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹609.6 Cr | -7.7% | 16.8% | 218.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -7.7% |
16.8% |
218.7% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses